Stock and Flow of Haemodialysis Patients Australia

Slides:



Advertisements
Similar presentations
ANZDATA Registry Annual Report 2013 STOCK AND FLOW CHAPTER 1.
Advertisements

Dialysis vs Transplant: the Australia & New Zealand experience Stephen McDonald ANZDATA Registry Adelaide, South Australia.
Kimberley Gill.  No risk of organ rejection, which can result in death even on medication.  Haemodialysis machines can be used at home.  No dependance.
EDWARD WELSH MARCH Dialysis Adequacy (?).
HEMODIALYSIS ADEQUACY HEMODIALYSIS ADEQUACY Laurie Vinci RN, BSN, CNN Laurie Vinci RN, BSN, CNN September 17, 2011 September 17, 2011.
HAEMODIALYSIS CHAPTER 5. © ANZDATA Registry Figure 5.1 Stock and Flow of Haemodialysis Patients Australia Patients new.
© ANZDATA Registry Method and Location of Dialysis 1453 (30%) 632 (13%) 1317 (27%) 1335 (27%) Number of Patients Australia 31-Dec-96.
Kidney Failure Noadswood Science, Kidney Failure To know medical treatments for kidney failure Thursday, September 17, 2015.
ANZDATA Registry Annual Report 2013 Philip Clayton CHAPTER 9 KIDNEY DONATION 2013 Annual Report - 36th Edition PERITONEAL DIALYSIS CHAPTER 6.
Kevan Polkinghorne Aarti Gulyani Stephen McDonald Kylie Hurst CHAPTER 5 HAEMODIALYSIS (including home haemodialysis) 2012 Annual Report—35th Edition ANZDATA.
CHAPTER 2 DIALYSIS IN MALAYSIA Goh Bak Leong Lim Yam Ngo Ong Loke Meng Ghazali Ahmad Lee Day Guat Source: 21 st MDTR Report 2013, NRR.
ANZDATA Registry Overview Dr Graeme Russ Darwin September 2001 September 2001.
CHAPTER 1: ALL RENAL REPLACEMENT THERAPY IN MALAYSIA Lim Yam Ngo Ong Loke Meng Goh Bak Leong Lee Day Guat Source: 20 th MDTR Report 2012, NRR.
© ANZDATA Registry Method and Location of Dialysis (31%) 634 (12%) 1396 (26%) 1523 (28%) Number of Patients Australia 30-Sep-98 METHA.BRIS98.
Chapter 5 Peritoneal Dialysis 2014 ANZDATA Registry 37th Annual Report Data to 31-Dec-2013 ANZDATA gratefully acknowledges the contributions of the Peritoneal.
Chapter 6 Home Dialysis 2014 ANZDATA Registry 37th Annual Report Data to 31-Dec-2013.
© ANZDATA Registry Prevalence and Incidence End Stage Renal Failure - Australia ( ) Per Million Functioning Transplant (259) New Pts (82) Deaths.
DEATHS CHAPTER 3. © ANZDATA Registry Figure 3.1 Survival among People who Commenced Dialysis 2001—2010 (Non-Indigenous) % (95% CI) Age at Start Time Period.
CHAPTER 11 Haemodialysis Practices Tan Chwee Choon Shahnaz Shah Firdaus Khan Rafidah Abdullah Norleen Bt Zulkarnain Sim Source: 20 th MDTR Report 2012,
STOCK AND FLOW CHAPTER 1. © ANZDATA Registry Figure 1.1 Prevalent Patients (Number Per Million Population at 31st December)
Blair Grace Kylie Hurst Stephen McDonald CHAPTER 1 STOCK AND FLOW 2012 Annual Report—35th Edition ANZDATA Registry Annual Report 2012.
© ANZDATA Registry Stock and Flow of CAPD Patients Australia Number of Patients 1504 Patients * (Data to 30 Sept) Extrapolated.
Chapter 1 ALL RENAL REPLACEMENT THERAPY IN MALAYSIA
ANZDATA Registry Annual Report 2013 Philip Clayton CHAPTER 9 KIDNEY DONATION 2013 Annual Report - 36th Edition DEATHS CHAPTER 3.
Figures from Dialysis and kidney transplantation in Australia 1991–2010.
Chronic Haemodialysis therapy in octogenarians with ESRF: demographics and outcomes from a single centre in England Dr Punit Yadav Dr Jyoti Baharani.
The use of Ferinject® (ferric carboxymaltase) in the treatment of iron deficiency in patients with renal anaemia Dr D Farrugia Dr S Ramakrishna E Gibson.
KT AS A QUALITY INDICATOR OF HAEMODIALYSIS ADEQUACY: COMPARISON OF KT/V, KT ACCORDING TO THE GENDER AND BODY SURFACE AREA The dialysis dose monitored with.
West Midlands Renal Peer Review
Prevalence (pmp) of Renal Replacement Therapy
ANZDATA Registry 39th Annual Report Chapter 13: End Stage Kidney Disease in Aotearoa/New Zealand Data to 31-Dec-2015.
Mortality rates in incident ESRD patients figure 9
Determinants of Overweight and Obesity in Lung Transplant Recipients
Fig 7.1 Median URR achieved in each renal unit
UK Renal Registry 16th Annual Report
December 31st point prevalent counts by modality figure 3.1
CHAPTER 6 PERITONEAL DIALYSIS Fiona Brown Aarti Gulyani
2013 Annual Report - 36th Edition
COMMIT/CCS-2 major efficacy results
CHAPTER 5 Paediatric Renal Replacement Therapy
CHAPTER 11: Haemodialysis Practices
CHAPTER 1 All Renal Replacement Therapy In Malaysia
CHAPTER 3 DEATHS Stephen McDonald 2012 Annual Report—35th Edition
West Midlands Renal Peer Review
Cause Specific Death Rates for All Dialysis Patients
UK Cystic Fibrosis Registry Annual Data Report 2017
Stephen P. McDonald  Kidney International Supplements 
2013 Annual Report - 36th Edition
Table 6.1.1: Stock and Flow, *based on year of death Year
ANZDATA Registry 41st Annual Report Highlights of End Stage Kidney Disease in Australia and New Zealand Data to 31-Dec-2017.
American Journal of Kidney Diseases
Volume 73, Issue 6, Pages (March 2008)
Update from the Haemodialysis Working Group
Dialysis outcomes in Australia & New Zealand
Number of Donors in Australia
ANZDATA Peritoneal Dialysis Report
UNITS OF TIME QUESTIONS.
Prevalent Dialysis and Transplants Australia (at 31st December) Number of Patients
Demographic Characteristics of Cohort
ANZDATA: Vascular Access
Table 6.1.1: Stock and Flow, Year
Stock and Flow of Peritoneal Dialysis Patients Australia
Stock and Flow of Peritoneal Dialysis Patients Australia
Stock and Flow of Peritoneal Dialysis Patients Australia
Stock and Flow of Peritoneal Dialysis Patients Australia
Stock and Flow of Haemodialysis Patients Australia
Australia and New Zealand
Australia and New Zealand
Distribution of facility mean treatment time, by DOPPS region and phase. Distribution of facility mean treatment time, by DOPPS region and phase. Restricted.
Presentation transcript:

Stock and Flow of Haemodialysis Patients Australia 1998 - 2002 Number of Patients New Patients Transplants Perm. Transfer Deaths No. Dialysing 5435 Patients 98 99 00 01 02

Stock and Flow of Haemodialysis Patients New Zealand 1998 - 2002 Number of Patients New Patients Transplants Perm. Transfer Deaths No. Dialysing 819 Patients 98 99 00 01 02

Age of New Haemodialysis Patients 2002 Australia No. Pats. 11 37 84 135 266 310 414 266 20

Age of Dialysing Haemodialysis Patients Australia 31-Dec-2002 No. Pats. 11 100 346 565 942 1150 1386 878 57

Age of New Haemodialysis Patients 2002 New Zealand No. Pats. 1 11 18 32 76 109 63 16 2

Age of Dialysing Haemodialysis Patients New Zealand 31-Dec-2002 No. Pats. 2 28 61 114 189 227 158 40 0

Duration of Dialysis Treatment Three Sessions Per Week Proportion (%) of Patients (31 March) Australia

Duration of Dialysis Treatment Three Sessions Per Week Proportion (%) of Patients (31 March) New Zealand

Haemodialysis Surface Area Number of Patients (31 March) Australia  139 207 133 212 64 980 340 1834 208 534 129 61 286 105 188 330 137 68 537 795 2021 189 421 150 16 545

Haemodialysis Surface Area New Zealand Number of Patients (31 March) 24 27 54 22 7 2 112 5 298 7 203 0 4 19 18 30 10 0 83 47 360 3 237 15

Australia Urea Reduction Ratio and Patient Survival Months Dialysis Three Times per Week March 1998 - March 2003 Australia Urea %  59 vs 60-64 p=0.03  59 vs 65-69 p=0.0001  59 vs  70 p=<0.0001 60-64 vs 65-69 p=0.09 60-65 vs  70 p=<0.0001 65-69 vs  70 p=0.0001 Months

New Zealand Urea Reduction Ratio and Patient Survival Dialysis Three Times per Week March 1998 - March 2003 New Zealand Urea %  59 vs 60-64 p=0.19  59 vs 65-69 p=0.56  59 vs  70 p=0.18 60-64 vs 65-69 p=0.0462 60-65 vs  70 p=0.88 65-69 vs  70 p=0.0339 Months

Haemodialysis Patient Survival Related to Hours per Week - Age >=18 Years Treatment at 90 days Australia 1993 - 2002 <12 vs 12-14.9 p=<0.001 <12 vs 15-17.9 p=<0.001 <12 vs >=18 p=<0.001 12-14.9 vs 15-17.9 p=<0.001 12-14.9 vs >=18 p=0.002 15-17.9 vs >=18 p=0.028 Years

Haemodialysis Patient Survival Related to B.M.I - Age >=18 Years Treatment at 90 days Australia 1993 - 2002 <20 vs 20-24.9 p=<0.001 <20 vs 25-29.9 p=<0.001 <20 vs >=30 p=0.006 20-24.9 vs 25-29.9 p=n.s 20-24.9 vs >=30 p=n.s 25-29.9 vs >=30 p=n.s Years

Haemodialysis Patient Survival Related to Weight - Age >=18 Years Treatment at 90 days Australia 1993 - 2002 <55 vs 55-69.9 p=n.s <55 vs 70-89.9 p=0.009 <55 vs >=90 p=0.001 55-69.9 vs 70-89.9 p=n.s 55-69.9 vs >=90 p=0.027 70-89.9 vs >=90 p=n.s Years

Type of Access for Haemodialysis Australia March 2003

Type of Access for Haemodialysis New Zealand March 2003